
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Noncoding RNAs as potential mediators of resistance to cancer immunotherapy
Radhakrishnan Vishnubalaji, Hibah Shaath, Ramesh Elango, et al.
Seminars in Cancer Biology (2019) Vol. 65, pp. 65-79
Closed Access | Times Cited: 73
Radhakrishnan Vishnubalaji, Hibah Shaath, Ramesh Elango, et al.
Seminars in Cancer Biology (2019) Vol. 65, pp. 65-79
Closed Access | Times Cited: 73
Showing 1-25 of 73 citing articles:
Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives
Jin‐Yu Sun, Dengke Zhang, Songquan Wu, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 182
Jin‐Yu Sun, Dengke Zhang, Songquan Wu, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 182
Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches
Hibah Shaath, Radhakrishnan Vishnubalaji, Ramesh Elango, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 325-345
Open Access | Times Cited: 95
Hibah Shaath, Radhakrishnan Vishnubalaji, Ramesh Elango, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 325-345
Open Access | Times Cited: 95
Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response
Radhakrishnan Vishnubalaji, Hibah Shaath, Nehad M. Alajez
Genes (2020) Vol. 11, Iss. 7, pp. 760-760
Open Access | Times Cited: 119
Radhakrishnan Vishnubalaji, Hibah Shaath, Nehad M. Alajez
Genes (2020) Vol. 11, Iss. 7, pp. 760-760
Open Access | Times Cited: 119
Immune‐related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinoma
Yaqiong Zhang, Liming Zhang, Youwen Xu, et al.
Journal of Cellular Physiology (2020) Vol. 235, Iss. 12, pp. 9304-9316
Closed Access | Times Cited: 92
Yaqiong Zhang, Liming Zhang, Youwen Xu, et al.
Journal of Cellular Physiology (2020) Vol. 235, Iss. 12, pp. 9304-9316
Closed Access | Times Cited: 92
Cellular senescence in hepatocellular carcinoma induced by a long non-coding RNA-encoded peptide PINT87aa by blocking FOXM1-mediated PHB2
Xiaohong Xiang, Yunong Fu, Kun Zhao, et al.
Theranostics (2021) Vol. 11, Iss. 10, pp. 4929-4944
Open Access | Times Cited: 89
Xiaohong Xiang, Yunong Fu, Kun Zhao, et al.
Theranostics (2021) Vol. 11, Iss. 10, pp. 4929-4944
Open Access | Times Cited: 89
Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma
Qianhui Xu, Yuxin Wang, Wen Huang
International Immunopharmacology (2021) Vol. 92, pp. 107333-107333
Closed Access | Times Cited: 74
Qianhui Xu, Yuxin Wang, Wen Huang
International Immunopharmacology (2021) Vol. 92, pp. 107333-107333
Closed Access | Times Cited: 74
Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer
Xueman Chen, Rong Luo, Yunmei Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 58
Xueman Chen, Rong Luo, Yunmei Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 58
Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer
Jindong Xie, W. H. Tian, Yuhui Tang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 38
Jindong Xie, W. H. Tian, Yuhui Tang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 38
MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in Chondrosarcoma
Palina Skipar, Mritunjoy Dey, Jakub Piątkowski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3176-3176
Open Access | Times Cited: 7
Palina Skipar, Mritunjoy Dey, Jakub Piątkowski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3176-3176
Open Access | Times Cited: 7
Immunotherapy in mastitis: state of knowledge, research gaps and way forward
Afnan Saleem, Sahar Saleem, Faith Omonijo, et al.
Veterinary Quarterly (2024) Vol. 44, Iss. 1, pp. 1-23
Open Access | Times Cited: 6
Afnan Saleem, Sahar Saleem, Faith Omonijo, et al.
Veterinary Quarterly (2024) Vol. 44, Iss. 1, pp. 1-23
Open Access | Times Cited: 6
Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs
Yei‐Tsung Chen, Lee Lee Wong, Oi Wah Liew, et al.
Cells (2019) Vol. 8, Iss. 12, pp. 1651-1651
Open Access | Times Cited: 49
Yei‐Tsung Chen, Lee Lee Wong, Oi Wah Liew, et al.
Cells (2019) Vol. 8, Iss. 12, pp. 1651-1651
Open Access | Times Cited: 49
MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM
Ramesh Elango, Khalid Alsaleh, Radhakrishnan Vishnubalaji, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 41
Ramesh Elango, Khalid Alsaleh, Radhakrishnan Vishnubalaji, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 41
EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma
Weimei Huang, Anqi Lin, Peng Luo, et al.
Cancer Gene Therapy (2020) Vol. 28, Iss. 7-8, pp. 864-874
Open Access | Times Cited: 41
Weimei Huang, Anqi Lin, Peng Luo, et al.
Cancer Gene Therapy (2020) Vol. 28, Iss. 7-8, pp. 864-874
Open Access | Times Cited: 41
Differential non-coding RNAs expression profiles of invasive and non-invasive pituitary adenomas
Ozal Beylerli, Dinar Khasanov, Ilgiz Gareev, et al.
Non-coding RNA Research (2021) Vol. 6, Iss. 3, pp. 115-122
Open Access | Times Cited: 35
Ozal Beylerli, Dinar Khasanov, Ilgiz Gareev, et al.
Non-coding RNA Research (2021) Vol. 6, Iss. 3, pp. 115-122
Open Access | Times Cited: 35
ceRNAs in Cancer: Mechanism and Functions in a Comprehensive Regulatory Network
Ni Yang, Kuo Liu, Mengxuan Yang, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 33
Ni Yang, Kuo Liu, Mengxuan Yang, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 33
Combination of epidrugs with immune checkpoint inhibitors in cancer immunotherapy: From theory to therapy
Ruoyu Guo, Jixia Li, Jinxia Hu, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110417-110417
Open Access | Times Cited: 16
Ruoyu Guo, Jixia Li, Jinxia Hu, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110417-110417
Open Access | Times Cited: 16
Contribution of a Circulating 2'-O-methylated MicroRNA Panel to the Diagnosis of Pancreatic Ductal Adenocarcinoma
Zilin Yang, Jia Huang, Xuejiao Wu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 6, pp. 1583-1592
Open Access | Times Cited: 5
Zilin Yang, Jia Huang, Xuejiao Wu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 6, pp. 1583-1592
Open Access | Times Cited: 5
CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells
Xiaoxue Jiang, Libo Xing, Yingjie Chen, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 23, pp. 310-323
Open Access | Times Cited: 38
Xiaoxue Jiang, Libo Xing, Yingjie Chen, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 23, pp. 310-323
Open Access | Times Cited: 38
Cancer‐derived non‐coding RNAs endow tumor microenvironment with immunosuppressive properties
Tong Hu, Run Shi, Yunru Gu, et al.
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Tong Hu, Run Shi, Yunru Gu, et al.
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
LncRNAs in Immune and Stromal Cells Remodel Phenotype of Cancer Cell and Tumor Microenvironment
Wenbin Li, Haohan Zhang, You Zuo, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3173-3185
Open Access | Times Cited: 4
Wenbin Li, Haohan Zhang, You Zuo, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3173-3185
Open Access | Times Cited: 4
Epigenetic modulation of immune cells: Mechanisms and implications
Stefano Fiordoro, Camillo Rosano, Eugenia Pechkova, et al.
Advances in Biological Regulation (2024) Vol. 94, pp. 101043-101043
Closed Access | Times Cited: 4
Stefano Fiordoro, Camillo Rosano, Eugenia Pechkova, et al.
Advances in Biological Regulation (2024) Vol. 94, pp. 101043-101043
Closed Access | Times Cited: 4
Transcriptome Analyses Reveal the Important miRNAs Involved in Immune Response of Gastric Cancer
Jin Wen, Jianli Liu, Tingyu Yang, et al.
IET Systems Biology (2025) Vol. 19, Iss. 1
Open Access
Jin Wen, Jianli Liu, Tingyu Yang, et al.
IET Systems Biology (2025) Vol. 19, Iss. 1
Open Access
Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer
Zeyu Zhang, Zhijie Xu, Yuanliang Yan
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 18
Zeyu Zhang, Zhijie Xu, Yuanliang Yan
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 18
A Comprehensive View of the Cancer-Immunity Cycle (CIC) in HPV-Mediated Cervical Cancer and Prospects for Emerging Therapeutic Opportunities
Jonathan Peña Avila, Bruno M. Carvalho, Eliane Campos Coimbra
Cancers (2023) Vol. 15, Iss. 4, pp. 1333-1333
Open Access | Times Cited: 10
Jonathan Peña Avila, Bruno M. Carvalho, Eliane Campos Coimbra
Cancers (2023) Vol. 15, Iss. 4, pp. 1333-1333
Open Access | Times Cited: 10